About the Authors

Koichi Mitsuya

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

k.mitsuya@scchr.jp

Affiliation Division of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan

Yoko Nakasu

Roles Conceptualization, Formal analysis, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing

Affiliation Division of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan

Nakamasa Hayashi

Roles Project administration, Validation

Affiliation Division of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan

Shoichi Deguchi

Roles Investigation

Affiliation Division of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan

Toshiaki Takahashi

Roles Conceptualization, Supervision

Affiliation Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan

Haruyasu Murakami

Roles Data curation

Affiliation Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan

Tateaki Naito

Roles Data curation

Affiliation Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan

Hirotsugu Kenmotsu

Roles Resources

Affiliation Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan

Akira Ono

Roles Investigation, Resources

Affiliation Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan

Kazushige Wakuda

Roles Investigation, Resources

Affiliation Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan

Hideyuki Harada

Roles Supervision

Affiliation Division of Radiation Oncology, Shizuoka Cancer Center, Shizuoka, Japan

Competing Interests

Dr. K. Mitsuya report personal fees from Accuray, Chugai Pharmaceutical, and Daiichi Sankyo outside the submitted work. Dr. T. Takahashi reports grants and personal fees from Ono Pharmaceutical, MSD, AstraZeneca, Chugai Pharmaceutical, Eli Lilly, grants from Pfizer, personal fees from Boehringer Ingelheim, Roche Diagnostics outside the submitted work. Dr. H. Murakami reports grants and personal fees from AstraZeneca, personal fees from Lilly Japan, Chugai Pharmaceutical, Boehringer Ingelheim, Phizer, Taiho Pharmaceutical, Novartis, Bristol-Myers Squibb, Ono Pharmaceutical, Merck Sharp & Dohme outside the submitted work. Dr. H. Kenmotsu reports grants and personal fees from AstraZeneca, Chugai Pharmaceutical, grants and personal fees from Boehringer Ingelheim during the conduct of the study, personal fees from Ono Pharmaceutical, Bristol-Myers, Eli Lilly, Kyowa Hakko Kirin, Novartis Pharma outside the submitted work. Dr. A. Ono reports grants and personal fees from Ono Pharmaceutical, Chugai Pharma, Taiho Pharmaceutical and research funding to our institution from Chugai Pharma and Taiho Pharmaceutical outside the submitted work. Dr. K. Wakuda reports Taiho Pharmaceutical, Boehringer Ingelheim, Ono Pharmaceutical outside the submitted work. Dr. H. Harada reports personal fees from BrainLAB, Chugai Pharmaceutical, AstraZeneca and Daiichi Sankyo outside the submitted work. Dr. Y. Nakasu, Dr. S. Deguchi, Dr. N. Hayashi, and Dr. T. Naito have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.